drugset

drugset / Trial / NCT02094378

A Study to Evaluate the Effect of Intranasal Esketamine on Cognitive Functioning in Healthy Subjects

NCT02094378 ↗

Phase 1 Completed 24 enrolled Janssen Research & Development, LLC

RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of this study is to assess the cognitive effects associated with administration of intranasal esketamine 84 mg.

Timeline

Start: 2014-06
Primary completion: 2014-08
Completion: 2014-08

Publications

Morrison RL, Fedgchin M, Singh J, Van Gerven J, Zuiker R, Lim KS, van der Ark P, Wajs E, Xi L, Zannikos P, Drevets WC. Effect of intranasal esketamine on cognitive functioning in healthy participants: a randomized, double-blind, placebo-controlled study. Psychopharmacology (Berl). 2018 Apr;235(4):1107-1119. doi: 10.1007/s00213-018-4828-5. Epub 2018 Feb 1.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Esketamine	Other / unclassified	84 mg	Intranasal

Indications

No indication recorded.